Trading is subdued with TG Therapeutics, Inc. (NASDAQ:TGTX) on Friday. But the shares remain in an uptrend and there is a good chance the trend will continue. TH Therapeutics recently staged a ...
To support the development and commercialization of a novel immunotherapy, biopharmaceutical company TG Therapeutics has signed a deal to license MaxCyte’s Flow Electroporation® technology and ExPERT™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results